VEGF, as an angiogenic factor that occurs in response to impairments, could be elevated by cytokines that promote inflammation, and the serum level of VEGF in RA patients was proposed as an indicator of RA progression (Taylor, 2002). This evidence concerns the gene VEGFA and rheumatoid arthritis.